Development of a cyanovirin-N-HIV-1 gp120 binding assay for high throughput screening of natural product extracts by time-resolved fluorescence

Journal of Biomolecular Screening

Volumn 5, Issue 3, 2000, Pages 169-176

  McMahon, James B ^a   Beutler, John A ^b   O'Keefe, Barry R ^a   Goodrum, Colby B B ^a   Myers, Marc A ^a   Boyd, Michael R ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b SAIC FREDERICK INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN GP 120; NATURAL PRODUCT;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; DRUG PROTEIN BINDING; FLUORESCENCE; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; NONHUMAN; PRIORITY JOURNAL; VIRUS TRANSMISSION;

ANIMALIA; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 0033933224     PISSN: 10870571     EISSN: None     Source Type: Journal    
DOI: 10.1177/108705710000500309     Document Type: Article

References (38)

1. Piot, P. (1998). The science of AIDS: A tale of two worlds. Science 280:1844-1845.
2. Moore, J.P. (1995). HIV vaccines: Back to primary school. Nature 376:115.
3. Burton, D.R. (1997). A vaccine for HIV type 1: The antibody perspective. Proc. Natl. Acad. Sci. U.S.A. 94:10018-10023.
4. Heillman, C.A., Baltimore, D. (1998). HIV vaccines - where are we going? Nat. Med. 4:532-534.
5. Merson, M.H. (1993). Slowing the spread of HIV: Agenda for the 1990's. Science 260:1266.
6. Rosenberg, M.J., Holmes, K.K., and The World Health Organization Working Group on Virucides. (1993). Virucides in prevention of HIV infection. Sex. Transm. Dis. 20:41-44.
7. Lange, J.M., Karam, M., Piot, P. (1993). Boost for vaginal microbicides against HIV. Lancet 342:1356.
8. Elias, C.J., Coggins, C. (1996). Female-controlled methods to prevent sexual transmission of HIV. AIDS 10:S43-S51.
9. Boyd, M.R., Gustafson, K.R., McMahon, J.B., Shoemaker, R.H., O'Keefe, B.R., Mori, T., Gulakowski, R.J., Wu, L., Rivera, M.I., Laurencot, C.M., Currens, M.J., Cardellina, J.H. II, Buckheit, R.W., Nara, P.I., Pannell, L.K., Sowder, R.C. II, Henderson, L.E. (1997). Discovery of cyanovirin-N, a novel immunodeficiency virus-inactivating protein that binds viral surface envelope glycoprotein gp120: Potential applications to microbicide development. Antimicrob. Agents Chemother. 41:1521-1530.
10. Gustafson, K.R., Sowder, R.C. II, Henderson, L.E., Cardellina, J.H. II, McMahon, J.B., Rajamani, U., Pannell, L.K., Boyd, M.R. (1997). Isolation, primary sequence determination, and disulfide bond structure of cyanovirin-N, an anti-HIV (human immunodeficiency virus) protein from the cyanobacterium Nostoc ellipsosporum. Biochem. Biophys. Res. Commun. 238:223-228.
11. Mori, T., Shoemaker, R.H., Gulakoswki, R.J., Krepps, B.L., McMahon, J.B., Gustafson, K.R., Pannell, L.K., Boyd, M.R. (1997). Analysis of sequence requirements for biological activity of cyanovirin-N, a potent HIV (human immunodeficiency virus)-inactivating protein. Biochem. Biophys. Res. Commun. 238:218-222.
12. Picardo, M.I., Hughes, K.T. (1997). Scintillation proximity assays. In Devlin, J.P. (ed.), High Throughput Screening: The Discovery of Bioactive Substances, pp. 307-316. Marcel Dekker, Inc., New York.
13. Rogers, M.V. (1997). Light on high throughput screening: Fluorescence-based assay technology. Drug Discov. Today 2:156-160.
14. Hemmilä, I.A., Webb, S. (1997). Time-resolved fluorometry: An overview of the labels and core technologies for drug screening applications. Drug Discov. Today 2:373-381.
15. Inglese, J., Samama, P., Patel, S., Burbaum, J., Stroke, I., Appell, K. (1998). Chemokine receptor-ligand interactions measured using time-resolved fluorescence. Biochemistry 37:2372-2377.
16. Liu, J., Gallagher, M., Horlick, R.A., Robbins, A.K., Webb, M.L. (1998). A time-resolved fluorometric assay for galanin receptors. J. Biomol. Screen. 3:199-206.
17. Mellor, G.W., Burden, M.N., Preaudat, M., Joseph, Y., Cooksley, S.B., Ellis, J.H., Banks, M.N. (1998). Development of a CD28/CD86 (B7-2) binding assay for high throughput screening by homogeneous time-resolved fluorescence. J. Biomol. Screen. 3:91-96.
18. Kolb, A.J., Burke, J.W., Mathis, G. (1997). A homogeneous, time-resolved fluorescence method for drug discovery. In Devlin, J.P. (ed.), High Throughput Screening: The Discovery of Bioactive Substances, pp. 345-360. Marcel Dekker, Inc., New York.
19. Hemmilä, I., Dakubu, S., Mukkala, V.-M., Siitari, H., Lovgren, T. (1984). Europium as a label in time-resolved immunofluorometric assay. Anal. Biochem. 137:335-343.
20. Spencer, R.W. (1998). High-throughput screening of historic collections: Observations on file size, biological targets, and file diversity. Biotechnol. Bioeng. 61:61-67.
21. Mori, T., Gustafson, K.R., Pannell, L.K., Shoemaker, R.H., Wu, L., McMahon, J.B., Boyd, M.R. (1998). Recombinant production of cyanovirin-N, a potent human immunodeficiency virus-inactivating protein derived from a cultured cyanobacterium. Protein Expr. Purif. 12:151-158.
22. Gulakowski, R.J., McMahon, J.B., Staley, P.G., Moran, R.A., Boyd, M.R. (1991). A semiautomated multiparameter assay for anti-HIV drug screening. J. Virol. Methods 33:87-100.
23. Parolis, L.A.S., Duus, J.Ø., Parolis, H., Meldal, M., Bock, K. (1996). The extracellular polysaccharide of Pichia (Hansenula) holstii NRRL Y-2448: The structure of the phosphomannan backbone. Carbohydr. Res. 293:101-117.
24. Parolis, L.A.S., Parolis, H., Kenne, L., Meldal, M., Bock, K. (1998). The extracellular polysaccharide of Pichia (Hansenula) holstii NRRL Y-2448: The phosphorylated side chains. Carbohydr. Res. 309:77-87.
25. Schmitz, F.J., Hollenbeak, K.H., Campbell D.C. (1978). Marine natural products: Halitoxin, toxic complex of several marine sponges of the genus Haliclona. J. Org. Chem. 43:3916-3922.
26. O'Keefe, B.R., Erim, T., Beutler, J.A., Cardellina, J.H. II, Gulakowski, R.J., Krepps, B.L., McMahon, J.B., Sowder, R.C., Johnson, D.G., Buckheit, R.W., Halliday, S.E., Boyd, M.R. (1998). Isolation and characterization of adociavirin, a novel HIV-inhibitory protein from the sponge Adocia sp. FEBS Lett. 431:85-90.
27. Zhang, J.H., Chung, T.D.Y., Oldenburg, K.R. (1999). A simple statistical parameter for use in evaluation and validation of high throughput screening assays. J. Biomol. Screen. 4:67-73.
28. Cardellina, J.H. II, Munro, M.H.G., Fuller, R.W., Manfredi, K.P., McKee, T.C., Tischler, M., Bokesch, H.R., Gustafson, K.R., Beutler, J.A., Boyd, M.R. (1993). A chemical screening strategy for the dereplication and prioritization of HIV-inhibitory aqueous natural products extracts. J. Nat. Prod. 56:1123-1129.
29. Moore, J.P., Trkola, A., Dragic, T. (1997). Co-receptors for HIV-1 entry. Curr. Opin. Immunol. 9:551.
30. DeClercq, E. (1993). Antiviral agents: Characteristic activity spectrum depending on the molecular target with which they interact. Adv. Viral Res. 42:1-55.
31. Matsuzaki, K., Ikeda, H., Masuma, R., Tanaka, H., Omura, S. (1995). Isochromophilones I and II. Novel inhibitors against gp120-CD4 binding produced by Pencillium multicolor FO-2338 I: Screening, taxonomy, fermentation, isolation and biological activity. J. Antibiot. (Tokyo) 48:703-707.
32. Matsuzaki, K., Tahara, H., Inokoshi, J., Tanaka, H., Masuma, R., Omura, S. (1998). New brominated and halogen-less derivatives and structure-activity relationship of azaphilones inhibiting gp120-CD4 binding. J. Antibiot. (Tokyo) 51:1004-1011.
33. Patil, A.D., Kumar, N.V., Kokke, W.C., Bean, M.F., Freyer, A.J., DeBrosse, C., Mai, S., Truneh, A., Faulkner, D.J., Carte, B., Breen, A.L., Hertzberg, R.P., Johnson, R.K., Westley, J.R., Potts, B.C.M. (1995). Novel alkaloids from the sponge Batzella sp.: Inhibitors of HIV gp120-human CD4 binding. J. Org. Chem. 60:1182-1188.
34. Tanaka, H., Matsuzaki, K., Nakashima, H., Ogino, T., Matsumoto, A., Ikeda, H., Woodruff, H.B., Omura, S. (1997). Chloropeptins, new anti-HIV antibiotics inhibiting gp120-CD4 binding from Streptomyces sp.: I. Taxonomy, fermentation, isolation, and physico-chemical properties and biological activities. J. Antibiot. (Tokyo) 50:58-65.
35. Mori, T., Shoemaker, R.H., McMahon, J.B., Gulakowski, R.J., Gustafson, K.R., Boyd, M.R. (1997). Construction and enhanced cytotoxicity of a [cyanovirin-N]-[Pseudomonas exotoxin] conjugate against human immunodeficiency virus-infected cells. Biochem. Biophys. Res. Commun. 239:884-888.
36. Esser, M.T., Mori, T., Mondor, I., Sattentau, Q.J., Dey, B., Berger, E.A., Boyd, M.R., Lifson, J.D. (1999). Cyanovirin-N binds to gp120 to interfere with CD4-dependent human immunodeficiency virus type 1 virion binding, fusion, and infectivity but does not affect the CD4 binding site on gp120 or soluble CD4-induced conformational changes in gp120. J. Virol. 73:4360-4371.
37. Beutler, J.A., McKee, T.C., Fuller, R.W., Tischler, M., Cardellina, J.H. II, Snader, K.M., McCloud, T.G., Boyd, M.R. (1993). Frequent occurrence of HIV-inhibitory sulphated polysaccharides in marine invertebrates. Antiviral Chem. Chemother. 4:167-172.
38. Boyd, M.R. (1988). Strategies for the identification of new agents for the treatment of AIDS: A national program to facilitate the discovery and preclinical development of new drug candidates for clinical evaluation. In: DeVita, V.T., Hellman, S., Rosenberg, S.A. (eds.), AIDS: Eitology, Diagnosis, Treatment and Prevention, pp. 305-319. Alan R. Liss, New York.